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A B ST R AC T 
 
 
Objective. To identify those who develop pulmonary embolism with D-
dimer levels by evaluating pulmonary CT angiographies of patients who are 
followed up with suspicion of coronavirus disease 2019 (COVID-19). 
Methods. Patients who were followed up in a community hospital with 
suspicion of COVID-19 and underwent Pulmonary CT angiography 
examination were evaluated. Clinical and demographic parameters and D-
Dimer values for patients with and without pulmonary embolism were 
evaluated in the pulmonary CT angiogram. Results. During the COVID-19 
pandemic, Thorax CT examination was performed in our center for 
suspicion or follow-up of COVID-19 infection in 3396 patients. Pulmonary 
CT angiography was applied to 312 (9.2%) of these cases. Of these 312 
patients, 141 were identified as COVID-19 patients. Acute pulmonary 
embolism was detected in 33 (23.4%) of 141 patients with COVID-19 and 
pulmonary CT angiogram. D-dimer levels (5964.97±4036.8 μg/L) of 
patients with COVID-19 infection and pulmonary embolism were 
significantly higher than D-dimer levels (972.4±1766.8 μg/L) of patients 
without pulmonary embolism. In patients with COVID-19 infection, a D-
dimer value higher than 1013 μg/L was determined as a cut-off value with 
100% sensitivity for the presence of pulmonary embolism. Conclusions. For 
those struggling with the COVID-19 pandemic, pulmonary embolism should 
be kept in mind if D-dimer values increase more than expected in the 
presence of respiratory distress that Thorax CT findings cannot explain.   
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In January 2020, a new coronavirus SARS-CoV-2 was 
identified as the cause of the viral pneumonia epidemic in 
Wuhan, China. This disease was later called coronavirus 
disease 2019 (COVID-19), as it spread rapidly and 
globally. The progression of COVID-19 includes primarily 
serious respiratory complications [1]. Patients may have 
fever, cough, abdominal pain and diarrhea. After the 
COVID-19 outbreak, acute pulmonary embolism reports 
related to COVID-19 have tended to increase. Several 
studies have reported clinical cases with isolated 
coagulopathy and pulmonary embolism with COVID-19 
pneumonia [2-4]. Also, elevated D-dimer levels have been 
reported in COVID-19 patients [5,6]. In addition, research 
provides evidence for a relationship between the severity 
of the disease and D-dimer levels [7]. The purpose of our 
study was to identify those who develop pulmonary 
embolism and detect if there is a correlation with D-dimer 
levels and pulmonary CT angiography findings in patients 
who are followed up due to suspected COVID-19. 
Materials and Methods 
Patient group 
This retrospective study was approved by Scientific 
Research Committee in the structure of Ministry of Health 
for COVID-19 research. The study was also approved 
(permit no: 135-24.09.20) by the institutional ethics 
committee for human clinical investigations which 
oversees the protocols in accordance with the Declaration 
of Helsinki. Patients who were followed-up with suspicion 
of COVID-19, and underwent pulmonary CT angiography 
between March 13 and May 20 at the Training and 
Research Public Hospital, were evaluated. Clinical and 
demographic parameters and D-Dimer values for patients 
with and without pulmonary embolism were evaluated in 
the pulmonary CT angiogram. 
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Pulmonary CT Angiography 
In our center, 128-multidetector tomography device 
(Optima CT660, General Electric Healthcare Systems, 
Milwaukee, USA) was used for examinations. Our 
standard display parameters: 120 kVp, 150-300 mAs, 
section thickness 1 mm and 0.6-1.4 pitch is determined 
depending on body size. “SmartPrep” protocol (GE 
Healthcare) was used as the monitoring system for the 
injection of contrast medium. SmartPrep is a feature that 
provides real-time tracking of contrast in part of its 
intended area. Follow-up images are taken as a low dose 
until the contrast medium reaches the preferred point and 
scanning is initiated by the operator. In our examinations, 
50-60 mL of iodinated contrast medium was injected 
through the antecubital vein at a rate of 4.0 mL/s with an 
18-to-20-gauge cannula. Images were reconstructed in the 
mediastinal and parenchymal windows with a slice 
thickness of 1 mm. The location of the pulmonary 
embolism by a single radiologist classified the main 
pulmonary arteries, lobar, segmental according to the most 
proximal location of the filling defect.  
Computed Tomography without contrast-media was 
performed in patients who were not suspected of 
pulmonary embolism and who requested CT for diagnosis 
or follow-up in terms of COVID-19 pneumonia. Non-
enhanced chest CT is preferably performed by using a low-
radiation-dose protocol to minimize radiation burden. 
Laboratory analysis 
D-dimer levels were recorded for all patients with 
pulmonary CT angiography. The last D-dimer 
measurements of the patients before the CTPA 
examination were evaluated. All patients with pulmonary 
CT angiography were evaluated with the Reverse 
Transcription Polymerase Chain Reaction (RT-PCR) test 
results for SARS-CoV-2. Necessary samples were 
obtained by nasopharyngeal swab. If necessary, second or 
third sampling was done using sputum or bronchoalveolar 
lavage. Any positive results were classified as confirmed 
COVID-19 infection. In a limited group of patients, in the 
early period of the pandemic, non-contrast thorax CT 
examination was used for diagnosis due to the suspicion of 
false negativity for PCR tests and late test results. In 
addition to PCR positive patients, Thorax CT images of 
RT-PCR negative patients were reviewed for comparison 
by a radiologist with 15 years of experience (AV), and 
patients were evaluated as COVID-19 in the presence of 
typical lung parenchymal lesions (bilateral and peripheral 
ground-glass opacities and / or alveolar consolidation) for 
COVID-19 [7,8]. 
Statistical Analysis 
Student t test was used for comparing the parameters 
between the two groups (Mean, Standard deviation, 
frequency). ROC curve analysis was used to determine the 
specificity and sensitivity values of D-dimer values and 
cut-off values. Significance was evaluated at the level of 
p<0.05. For all analyses, Statistical Package for the Social 
Science 22 (version 22 for Windows; SPSS, Turkey) 
program was used.  
Results 
The flow chart of all patients who applied to the 
emergency department between 13 March and 20 May 
2020 in our public hospital, who underwent CT scan, is 
shown in Figure 1.  
 
Figure 1. Flowchart of the study. 
During this time, Thorax CT examination was 
performed in 3396 patients for suspicion or follow-up of 
COVID-19 infection. Pulmonary CT angiography was 
applied to 312/3396 (9.2%) of these cases. Of these 312 
patients, 141 patients were classified as COVID-19 
infections (111 patients were positive RT-PCR and 30 
patients were positive Thorax CT). The reason for 
requesting CT angiography in these patients was high D-
Dimer values in 88/141 (62%) patients, and respiratory 
distress in 53/141 (38%) patients that could not be 
explained by Thorax CT findings. 83 of our patients were 
male (59%) and 58 were female (41%). The age range of 
our patients was 23-95, and the mean age was calculated as 
64.88±18.6 for male patients, 61.04±17.1 for female 
patients and 62.62±17.8 for all patients. Acute pulmonary 
embolism was detected in 33 (23.4%) of 141 patients with 
COVID-19 and pulmonary CT angiogram (Figures 2, 3). 
There were no signs of pulmonary embolism in 108 
patients (76.6%). Relevant clinical and tomography data 
are summarized in Table 1 and Table 2. 
D-dimer levels (5964.97±4036.8 μg/L) of patients with 
COVID-19 infection and pulmonary embolism were 
significantly higher than D-dimer levels (972.4±1766.8 
μg/L) of patients without pulmonary embolism (p<0.05). 
In follow-up of 141 patients, 21/33 (64%) of patients with 
pulmonary embolism and 19/108 (18%) of patients without 
pulmonary embolism needed intensive care treatment 
(p<0.05). Follow-up resulted in death in 10/33 (30%) of 
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patients with pulmonary embolism and in 5/108 (4.6%) of 
patients without pulmonary embolism (p<0.05) (Table 1). 
In patients with COVID-19 infection, a D-dimer value 
greater than 1013 μg/L had 33/33 (100%, 95% CI) 
sensitivity and 78/108 (72%, 95% CI) specificity for the 
presence of pulmonary embolism.  
 
Figure 2. Pulmonary computed tomographic angiography 
(PCTA) demonstrating saddle pulmonary embolism (PE) 
as well as emboli partially obstructing both main 
pulmonary arteries. A 33-year-old male patient has been 
followed for 4 days with the diagnosis of COVID-19, and 
PCTA was performed due to the increased dyspnea with a 
rapid increase in D-dimer values. 
The D-dimer levels of 171 patients whose PCR tests for 
COVID-19 were negative but were applied CTPA due to 
increased D-dimer levels were found to be 711 ± 416.5 μg 
/ L. Pulmonary embolism was detected in 13 (7.6%) of 171 
patients with negative COVID-19 tests. 
 
Figure 3. Axial CT angiography scan of the chest shows 
filling defects in the left lower lobe pulmonary arteries 
representing clots (mediastinal window) and findings 
compatible with COVID-19 pneumonia (lung window). 
 
 
Table 1. Patient Demographics. The values are given as average/median PE: Pulmonary embolism. 
 Total  
(n, % or SD)  
With PE   
(n, % or SD) 
Without PE     
(n, % or SD) 
 
n=141 n=33 n=108 p value 
Age (years) 62.62±17.8 65.52±18.5 61.73±17.5 .286 
Male 69(49) 17(52) 52(48) .425 
D-dimer (μg /L) 2191.7±3231.6 6034.7±3950.7  1017.5±1746.4 .001 
ICU Hospitalization 40(28) 21(64) 19(18) .001 
Mortality  15(11) 10(30) 5(4.6) .001 
     
Table 2: Location of embolus on Chest CT 
 N, % 










                     




Despite the need for improvement in infectious 
involvement in the lung parenchyma in COVID-19 
patients, high oxygen requirement continues and it may 
even increase due to the development of thromboembolic 
disease [9]. Myocardial damage has been reported to be 
associated with a fatal course in COVID-19 patients, with 
mortality rates reaching 37% in patients without prior 
cardiovascular disease but with high troponin levels [10]. 
Previous studies have shown poor prognosis in COVID-19 
cases, with low comorbidity in patients with severe 
comorbidity, with low platelet levels, increased d-dimer 
levels, and increased prothrombin levels [11]. D-dimer 
levels higher than 1 μg/mL in COVID-19 patients have 
been identified as an important risk factor for mortality 
[12]. Autopsy reports of COVID-19 patients showed 
microtrombus in the lungs and other organs with bleeding 
focus [13,14]. These findings show that cytokine storm and 
associated hypoxaemia lead to severe endothelial 
dysfunction, causing intravascular coagulation and 
thromboembolic complications. Although some 
underlying conditions have affected the coagulation 
process in these patients, the hypothesis that 
hypercoagulability is due to endothelial dysfunction makes 
sense. Case studies support observations that show that 
anticoagulation reduces mortality rates for COVID-19 
patients [15]. Follow-up of diffuse intravascular 
coagulation and measurement of platelet counts, D-dimer 
and fibrinogen levels, assessment of the International 
Society on Thrombosis and Haemostasis scores may be 
useful for early diagnosis of PE in patients with COVID-
19 [9]. A normal level of D-dimer may enable the 
exclusion of pulmonary embolism in patients who are 
clinically unlikely to have PE. However, the increase in D-
dimer level hinders the use of thrombosis as a precise 
marker due to lack of specificity. The European Society of 
Radiology and the European Society of Thoracic Imaging 
recommend performing contrast CT to exclude PE if 
additional oxygen is needed in patients with COVID-19 
pneumonia with limited disease spread [16]. Similarly, the 
European Society of Cardiology recommends CTPA 
before the patient leaves the radiology department if the 
findings obtained with non-contrast CT are not advanced 
enough to explain severe respiratory failure [17].  
It has been observed that pulmonary embolism and 
deep vein thrombosis (DVT) occur in other viral 
pneumonias, but not as often as in COVID-19 patients. It 
was reported that seven (5.9%) of 119 people who applied 
to the hospital with influenza A H1N1 virus infection 
developed thrombotic vascular events, one of which was 
PE and three were DVT [18].  
In our center, which is one of the sites designated as a 
pandemic hospital, we evaluated patients admitted with the 
suspicion of COVID-19. The use of the D-dimer test is not 
recommended due to false positive results during clinical 
evaluation. Although there is no evidence of pneumonia in 
the COVID-19 patients to explain the respiratory distress 
in the non-contrast Thoracic CT examination, pulmonary 
CT angiography is recommended with high risk in case of 
severe respiratory distress and increased oxygen support 
requirement. It is recommended to perform D-dimer tests 
in patients with low and moderate risk of pulmonary 
embolism, and CT angiography if D-dimer results are 
positive. Because D-dimer values increase with age [19], it 
is recommended to accept age-adjusted limit values (such 
as, age x 10 μg/L) for the D-dimer instead of a fixed cut-
off value. Although there is no pulmonary embolism in 
COVID-19 patients, increased D-dimer levels have been 
reported compared to normal [20]. In our center, D-dimer 
levels above 500 μg/L in COVID-19 patients are 
considered sufficiently high in order to request pulmonary 
CT angiography. All of the patients included in the study 
were positive for the RT-PCR test or with typical signs of 
COVID-19 pneumonia on Thoracic CT examination. 
Acute pulmonary embolism was present in 33/141 (23.6%) 
of the patients. This rate of pulmonary embolism is 
significantly higher than the rates encountered in critically 
ill patients (1.3%) [21] or emergency service patients (3 to 
10%) without COVID-19 infection [22].  
In our patient population, a D-dimer threshold of 1013 
μg/L detected all patients with pulmonary embolism on 
chest CT. This 1013 μg/L threshold is a value between 
2660 [9], 2400 [23] and 900 [5] previously reported. These 
cut-off values are normally higher than the cut-off values 
used to exclude pulmonary embolism, as COVID-19 
patients have increased D-dimer levels without pulmonary 
embolism, which may be associated with a systemic 
inflammatory response [24].  
Hydroxychloroquine and favipiravir treatment was 
administered to patients who were diagnosed with COVID-
19 in the early period of the pandemic in which patients 
admitted to the study were followed, but anticoagulants 
were not used for routine prophylaxis. At the time of 
writing the article, 2x60 mg of enoxaparin sodium was 
added to the routine treatment protocol of patients with 
COVID-19 pneumonia. Although a more detailed 
assessment is required, after anticoagulant prophylaxis was 
initiated, there was a decrease in high D-dimer levels and 
the need for CTPA. 
Our study has several limitations. First, it is not possible 
to accurately determine the incidence of PE in COVID-19 
patients since CTPA examination is not performed in all 
patients. Since our study was conducted in a retrospective 
manner, it was not possible to determine exactly why PE 
was suspected in terms of the examination decision in all 
patients. For similar reasons, the comorbidities of patients 
in terms of thromboembolism and past venous thrombosis 
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histories could not be evaluated. In addition, patients were 
not evaluated for deep vein thrombosis. 
Highlights 
✓ Increased D-dimer levels are often seen in patients 
with COVID-19 pneumonia. 
✓ There appears to be a strong association between high 
D-dimer levels and thrombotic complications in 
COVID-19 patients. 
✓ Prophylaxis with anticoagulant agents may improve 
prognosis in patients with COVID-19 pneumonia. 
Conclusions 
Although performed at a single center and with a 
limited number of patients, we our study may provide 
useful information for those fighting the COVID-19 
pandemic. In the presence of respiratory distress that 
thorax CT findings cannot explain, pulmonary embolism 
should be kept in mind if D-dimer values increase more 
than expected. Our findings may provide guidance in 
making a decision for pulmonary CT angiography. In 
addition, studies with more patients are required to 
establish consensus regarding the use of anticoagulants as 
prophylactic in COVID-19 patients whose clinical 
situation has deteriorated.  
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